| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/07/2006 | EP1664272A2 Targeting endothelium for tissue-specific delivery of agents |
| 06/07/2006 | EP1664076A2 Taxane chemosensitivity prediction test |
| 06/07/2006 | EP1664055A1 9-amino-podophyllotoxin derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 06/07/2006 | EP1664047A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/07/2006 | EP1664039A1 1,3-benzoxazolyl derivatives as kinase-inhibitors |
| 06/07/2006 | EP1664033A2 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 06/07/2006 | EP1664032A1 N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors |
| 06/07/2006 | EP1664030A1 Quinazoline derivatives |
| 06/07/2006 | EP1664029A1 Quinazoline derivatives as antitumor agents |
| 06/07/2006 | EP1664028A1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 06/07/2006 | EP1664027A1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
| 06/07/2006 | EP1664026A1 Mitotic kinesin inhibitors |
| 06/07/2006 | EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors |
| 06/07/2006 | EP1664013A1 Calcilytic compounds |
| 06/07/2006 | EP1663978A2 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663933A2 Improved delivery by labile hydrophobic modification of drugs |
| 06/07/2006 | EP1663340A2 Catheter balloon systems and methods |
| 06/07/2006 | EP1663320A1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 06/07/2006 | EP1663307A2 Method for treating, preventing and/or diagnosing cancer, related to the use of mal2 polypeptide |
| 06/07/2006 | EP1663306A2 Antibodies with altered effector functions |
| 06/07/2006 | EP1663290A2 Modulators of p-selectin glycoprotein ligand 1 |
| 06/07/2006 | EP1663260A1 Chemotherapeutic antineoplastic treatment |
| 06/07/2006 | EP1663259A2 Compositions and methods for treatment of cancer |
| 06/07/2006 | EP1663258A2 Pharmaceutical compositions and therapeutic treatment with oligo-beta- (1,3) - glucans |
| 06/07/2006 | EP1663251A1 Use of 2-methylene-19-nor-20(s)-1a,25-dihydroxyvitamin d3 to increase the life expectancy of human beings |
| 06/07/2006 | EP1663249A1 1,3-DIACLYATED,26,27-ALKYL/HALOALKYL VITAMIN D sb 3 /sb COMPOUNDS AND METHODS OF USE THEREOF |
| 06/07/2006 | EP1663244A2 Pteridine derivatives for the treatment of septic shock and tnf-alpha-related diseases. |
| 06/07/2006 | EP1663241A1 5-arylpyrimidines as anticancer agents |
| 06/07/2006 | EP1663239A2 Potassium channel mediated delivery of agents through the blood-brain barrier |
| 06/07/2006 | EP1663236A1 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-¬1,3,4-oxadiazol-2-yl| phenyl)pyridine-3-sulphonamide and an lhrh analogue and/or a biphosphonate |
| 06/07/2006 | EP1663214A1 Cancer treatment with epothilones |
| 06/07/2006 | EP1663211A1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 06/07/2006 | EP1663201A1 A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 06/07/2006 | EP1663198A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 06/07/2006 | EP1663194A2 Method of treating cancer with hdac inhibitors |
| 06/07/2006 | EP1663181A2 Protein binding compounds |
| 06/07/2006 | EP1494999B1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1446106A4 Optimal polymer mixtures for gastric retentive tablets |
| 06/07/2006 | EP1434787A4 Lp mammalian proteins; related reagents |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1352051B1 In vivo animal model of human leukemia |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1174126B1 Antibody and polyalkylene glycol-bonded liposome |
| 06/07/2006 | EP1164198B1 Method for screening anticancer agent |
| 06/07/2006 | EP1068870B1 Antitumor agents |
| 06/07/2006 | EP1068233B1 Transcription factors and their use |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 06/07/2006 | EP1045698B1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | CN1784426A Antibody targeted at antigen specific to cancer |
| 06/07/2006 | CN1784424A Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 06/07/2006 | CN1784382A 7-amino- isoindolyl compounds amd their pharmaceutical uses |
| 06/07/2006 | CN1784242A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 06/07/2006 | CN1784234A Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |
| 06/07/2006 | CN1784232A Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 06/07/2006 | CN1784231A 1-amino 1H-imidazoquinolines |
| 06/07/2006 | CN1782085A Human growth colyone receptor 2 subtgpe and E.coli cytosine deaminizing enzyme co-expression vector and its establishing and use |
| 06/07/2006 | CN1782078A Heavy Chain and light chain variable area gene of mouse antihuman lipopolysaccharide acceptor antibody and its use |
| 06/07/2006 | CN1782072A Vector |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781935A Novel LHRH antagonist |
| 06/07/2006 | CN1781934A HER-2 analogue antigen epitope and peptide containing said epitope |
| 06/07/2006 | CN1781932A Adriamycin derivative and its preparing method and use |
| 06/07/2006 | CN1781927A Mevalonic acid derivative |
| 06/07/2006 | CN1781922A Camptothecine derivative, preparing method and use |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781551A Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor |
| 06/07/2006 | CN1781529A Liuweidihuang multiple vatimines and its preparing method |
| 06/07/2006 | CN1781513A Lozenge for choke |
| 06/07/2006 | CN1781495A Oral and external application for preventing and treating tumor |
| 06/07/2006 | CN1781491A Treating agent of plant poly pentene alcohol gor liver damage |
| 06/07/2006 | CN1781479A Chinese small iris seed agent dispersion system and its preparing method |
| 06/07/2006 | CN1781478A Use of lushan rabdosia A agent and its derivatives analog in preparing anti-cancer medicine |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/07/2006 | CN1258534C Cytotoxic alkaloid derivatives including asmarine A and B isolated from a sponge |
| 06/07/2006 | CN1258377C Bamboo extract and its preparation method and application |
| 06/07/2006 | CN1258364C Formula of cucurbitacin dripping pills and its preparation method |
| 06/07/2006 | CN1258362C Use of substituted acryloyl stallimycin derivatives in treatment of tumors associated with high levels of glutathione |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/07/2006 | CN1258358C Polymeric micelle composition |
| 06/06/2006 | US7057059 Tumor-inhibiting platinum (II) oxalate complexes |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7056952 Isoflavone metabolites |
| 06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 06/06/2006 | US7056913 for example, 7-methoxy-8-[n'-(4''-acridonylcarboxyamido)alkyl]-oxy-(11aS)-1,2,3,11a-tetraydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one; antitumor agents |
| 06/06/2006 | US7056912 Heteroaryl derivatives and their use as medicaments |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |